CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | -55.6% | 700 | -56.2% | 0.00% | – |
| Q1 2018 | $9,000 | +50.0% | 1,600 | +40.0% | 0.00% | – |
| Q4 2017 | $6,000 | -64.7% | 1,143 | -65.0% | 0.00% | – |
| Q3 2017 | $17,000 | +183.3% | 3,268 | +195.2% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 1,107 | +10.1% | 0.00% | – |
| Q1 2017 | $6,000 | +200.0% | 1,005 | +402.5% | 0.00% | – |
| Q3 2013 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|